A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
Clinical trial NCT05901649 · COMPLETED
Trial details
- NCT number
- NCT05901649
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-05
- Primary completion
- 2026-06-16
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.